Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis


BOZ C. , TERZİ M., Ozer B., Turkoglu R., KARABUDAK R., EFENDİ H., ...Daha Fazla

MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.36, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 36
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.msard.2019.101376
  • Dergi Adı: MULTIPLE SCLEROSIS AND RELATED DISORDERS

Özet

Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting multiple sclerosis (RRMS). These have not been compared in controlled trials, but only in observational studies, with inconclusive results. Comparison of their effect on relapse and disability in a real-world setting is therefore needed.